190 related articles for article (PubMed ID: 38236913)
1. AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer.
Ito T; Saito A; Kamikawa Y; Nakazawa N; Imaizumi K
Mol Cancer Res; 2024 Apr; 22(4):373-385. PubMed ID: 38236913
[TBL] [Abstract][Full Text] [Related]
2. The androgen-induced protein AIbZIP facilitates proliferation of prostate cancer cells through downregulation of p21 expression.
Cui X; Cui M; Asada R; Kanemoto S; Saito A; Matsuhisa K; Kaneko M; Imaizumi K
Sci Rep; 2016 Nov; 6():37310. PubMed ID: 27853318
[TBL] [Abstract][Full Text] [Related]
3. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
4. Androgen-regulated transcription factor AIbZIP in prostate cancer.
Labrie C; Lessard J; Ben Aicha S; Savard MP; Pelletier M; Fournier A; Lavergne E; Calvo E
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):237-44. PubMed ID: 17933519
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C
Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038
[TBL] [Abstract][Full Text] [Related]
6. Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Coussy F; Lavigne M; de Koning L; Botty RE; Nemati F; Naguez A; Bataillon G; Ouine B; Dahmani A; Montaudon E; Painsec P; Chateau-Joubert S; Laetitia F; Larcher T; Vacher S; Chemlali W; Briaux A; Melaabi S; Salomon AV; Guinebretiere JM; Bieche I; Marangoni E
Theranostics; 2020; 10(4):1531-1543. PubMed ID: 32042320
[TBL] [Abstract][Full Text] [Related]
7. AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells.
Li S; Lee W; Heo W; Son HY; Her Y; Kim JI; Moon HG
J Breast Cancer; 2023 Feb; 26(1):60-76. PubMed ID: 36762781
[TBL] [Abstract][Full Text] [Related]
8. Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis.
Liao Y; Li S; An J; Yu X; Tan X; Gui Y; Wang Y; Huang L; Zhou S; Wang D
Phytomedicine; 2023 Jul; 116():154856. PubMed ID: 37187035
[TBL] [Abstract][Full Text] [Related]
9. CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.
Haque I; Banerjee S; De A; Maity G; Sarkar S; Majumdar M; Jha SS; McGragor D; Banerjee SK
Oncogene; 2015 Jun; 34(24):3152-63. PubMed ID: 25132260
[TBL] [Abstract][Full Text] [Related]
10. Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.
Thompson KJ; Leon-Ferre RA; Sinnwell JP; Zahrieh DM; Suman VJ; Metzger FO; Asad S; Stover DG; Carey L; Sikov WM; Ingle JN; Liu MC; Carter JM; Klee EW; Weinshilboum RM; Boughey JC; Wang L; Couch FJ; Goetz MP; Kalari KR
NAR Cancer; 2022 Jun; 4(2):zcac018. PubMed ID: 35734391
[TBL] [Abstract][Full Text] [Related]
11. Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features.
Vtorushin S; Dulesova A; Krakhmal N
J Zhejiang Univ Sci B; 2022 Aug; 23(8):617-624. PubMed ID: 35953756
[TBL] [Abstract][Full Text] [Related]
12. The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway.
Zhang J; Zhang X; Li Z; Wang Q; Shi Y; Jiang X; Sun X
Front Oncol; 2021; 11():654672. PubMed ID: 33912463
[TBL] [Abstract][Full Text] [Related]
13. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.
Fagan-Solis KD; Pentecost BT; Gozgit JM; Bentley BA; Marconi SM; Otis CN; Anderton DL; Schneider SS; Arcaro KF
J Cell Physiol; 2014 Sep; 229(9):1160-9. PubMed ID: 24443386
[TBL] [Abstract][Full Text] [Related]
14. Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.
Barton VN; D'Amato NC; Gordon MA; Lind HT; Spoelstra NS; Babbs BL; Heinz RE; Elias A; Jedlicka P; Jacobsen BM; Richer JK
Mol Cancer Ther; 2015 Mar; 14(3):769-78. PubMed ID: 25713333
[TBL] [Abstract][Full Text] [Related]
15. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
Li G; Yang M; Zuo L; Wang MX
Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
[TBL] [Abstract][Full Text] [Related]
16. A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes.
Yoo TK; Kang J; Lee A; Chae BJ
Breast Cancer Res Treat; 2022 Feb; 191(3):599-610. PubMed ID: 35018542
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers.
Limsakul P; Choochuen P; Charupanit G; Charupanit K
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672350
[TBL] [Abstract][Full Text] [Related]
19. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.
Zeng D; Xiao Y; Zhu J; Peng C; Liang W; Lin H
Cancer Manag Res; 2019; 11():143-156. PubMed ID: 30613163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
